CD4 and cancer: Such inflammatory mechanisms, specifically involving IL-6 and STAT3 signalling8,9, neutrophils and neutrophil extracellular traps10, as well as the CD4+ cell–macrophage axis11, have been identified as regulators of metastatic processes in cancer.